See all
 |
Articles: Pharmacology/Therapy |
Prior Articles
MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951
Journal of Clinical Oncology, 11/20/09
Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma
British Journal of Haematology, 11/20/09 Use of Oral N-Acetylcysteine for Protection of Melanocytic Nevi against UV-Induced Oxidative Stress: Towards a Novel Paradigm for Melanoma Chemoprevention
Clinical Cancer Research, 11/20/09 Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer
British Journal of Cancer, 11/20/09 The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with non-acute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3 and CEBPA
Blood, 11/19/09 Phase II study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first-line chemotherapy for advanced mullerian tumors
Journal of Clinical Oncology, 11/19/09 Phase II multicenter trial of maintenance biotherapy after induction concurrent biochemotherapy for patients with metastatic melanoma
Journal of Clinical Oncology, 11/19/09 Randomized, double-blind trial of carboplatin and paclitaxel with either daily oral cediranib or placebo in advanced non-small-cell lung cancer: NCIC Clinical Trials Group BR24 Study
Journal of Clinical Oncology, 11/19/09 Phase II trial of single-agent oral vinorelbine in elderly (70 years) patients with advanced non-small-cell lung cancer and poor performance status
Annals of Oncology, 11/19/09 Exclusive Author Commentary Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma
European Journal of Endocrinology, 11/19/09 A Pilot Study for Combination Chemotherapy Using Gemcitabine and S-1 for Advanced Pancreatic Cancer
Oncology (Karger), 11/19/09 Combined treatment strategies in gastrointestinal stromal tumors (GISTs) after imatinib and sunitinib therapy
Cancer Treatment Reviews, 11/19/09 Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin
Cancer, 11/19/09 The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater
Medical Oncology, 11/19/09 The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cells
Molecular Carcinogenesis, 11/19/09 Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma
European Journal of Cancer, 11/19/09 Pharmacogenetics and pharmacoepigenetics of gemcitabine
Medical Oncology, 11/19/09 Hand-Foot Syndrome (Hand-Foot Skin Reaction, Palmar-Plantar Erythrodysesthesia): Focus on Sorafenib and Sunitinib
Oncology (Karger), 11/19/09 Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer – a multi-centre randomised phase II study
British Journal of Cancer, 11/18/09 Multicenter phase 2 study of belotecan, a new camptothecin analog, and cisplatin for chemotherapy-naive patients with extensive-disease small cell lung cancer
Cancer, 11/18/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|